Key result
Common BCL11B variation links to increased aortic stiffness and higher cardiovascular risk.
Why the study?
Does common genetic variation in the 3'-BCL11B gene desert associate with increased aortic stiffness (carotid-femoral pulse wave velocity) in adults of European ancestry?
Meta-Analysis (n=25,940)
Yes
Does common genetic variation in the 3'-BCL11B gene desert associate with increased aortic stiffness (carotid-femoral pulse wave velocity) in adults of European ancestry?
Standardized Mean Difference: -0.076
p-value: p=3.1×10(-15)
Identification of a novel genomic locus in the BCL11B gene desert associated with aortic stiffness provides a potential new pathway and therapeutic target for reducing cardiovascular disease risk.
Supports novel BCL11B locus for aortic stiffness; extends genetic CVD insights but remains hypothesis-generating.
BACKGROUND: Carotid-femoral pulse wave velocity (CFPWV) is a heritable measure of aortic stiffness that is strongly associated with increased risk for major cardiovascular disease events. METHODS AND RESULTS: We conducted a meta-analysis of genome-wide association data in 9 community-based European ancestry cohorts consisting of 20 634 participants. Results were replicated in 2 additional European ancestry cohorts involving 5306 participants. Based on a preliminary analysis of 6 cohorts, we identified a locus on chromosome 14 in the 3'-BCL11B gene desert that is associated with CFPWV (rs7152623, minor allele frequency=0.42, β=-0.075±0.012 SD/allele, P=2.8×10(-10); replication β=-0.086±0.020 SD/allele, P=1.4×10(-6)). Combined results for rs7152623 from 11 cohorts gave β=-0.076±0.010 SD/allele, P=3.1×10(-15). The association persisted when adjusted for mean arterial pressure (β=-0.060±0.009 SD/allele, P=1.0×10(-11)). Results were consistent in younger (<55 years, 6 cohorts, n=13 914, β=-0.081±0.014 SD/allele, P=2.3×10(-9)) and older (9 cohorts, n=12 026, β=-0.061±0.014 SD/allele, P=9.4×10(-6)) participants. In separate meta-analyses, the locus was associated with increased risk for coronary artery disease (hazard ratio=1.05; confidence interval=1.02-1.08; P=0.0013) and heart failure (hazard ratio=1.10, CI=1.03-1.16, P=0.004). CONCLUSIONS: Common genetic variation in a locus in the BCL11B gene desert that is thought to harbor 1 or more gene enhancers is associated with higher CFPWV and increased risk for cardiovascular disease. Elucidation of the role this novel locus plays in aortic stiffness may facilitate development of therapeutic interventions that limit aortic stiffening and related cardiovascular disease events.
No takes yet. Share an insight, caveat, or question.
Mitchell et al. (2011) conducted a meta-analysis in Aortic stiffness (assessed by carotid-femoral pulse wave velocity) (n=25,940). Common genetic variation in the 3'-BCL11B gene desert (rs7152623) vs. Reference allele was evaluated on Carotid-femoral pulse wave velocity (CFPWV) (beta=-0.076 ± 0.010 SD/allele, p=3.1×10(-15)). Common genetic variation at rs7152623 in the 3'-BCL11B gene desert was significantly associated with increased carotid-femoral pulse wave velocity (beta=-0.076 SD/allele, P=3.1×10^-15) and cardiovascular disease risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: